Physiologic intestinal 18F-FDG uptake is associated with alteration of gut microbiota and proinflammatory cytokine levels in breast cancer

[1]  Juan M. Astorga,et al.  Breast Cancer and Its Relationship with the Microbiota , 2018, International journal of environmental research and public health.

[2]  Timothy R Church,et al.  A taxonomic signature of obesity in a large study of American adults , 2018, Scientific Reports.

[3]  D. Raoult,et al.  New Insights in Gut Microbiota and Mucosal Immunity of the Small Intestine , 2018 .

[4]  S. Houshmand,et al.  Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT , 2018, PloS one.

[5]  M. Sabater,et al.  Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota , 2018, The ISME Journal.

[6]  Menghui Zhang,et al.  Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients , 2017, Front. Microbiol..

[7]  D. Laukens,et al.  Butyrate-producing bacteria supplemented in vitro to Crohn’s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity , 2017, Scientific Reports.

[8]  Yeojun Yun,et al.  Gut microbiota and physiologic bowel 18F-FDG uptake , 2017, EJNMMI Research.

[9]  Philipp Koehn,et al.  Cognitive Psychology , 1992, Ageing and Society.

[10]  Eric A. Franzosa,et al.  Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity , 2016, Cell.

[11]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[12]  Yeojun Yun,et al.  Background Intestinal 18F-FDG Uptake Is Related to Serum Lipid Profile and Obesity in Breast Cancer Patients , 2015, PloS one.

[13]  A. Jayaraman,et al.  Characterization of Microbial Dysbiosis and Metabolomic Changes in Dogs with Acute Diarrhea , 2015, PloS one.

[14]  M. Vetizou,et al.  Cancer and the gut microbiota: An unexpected link , 2015, Science Translational Medicine.

[15]  Daryl J. Selen,et al.  Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans , 2014, Nuclear medicine communications.

[16]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[17]  Jacques Ravel,et al.  An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform , 2014, Microbiome.

[18]  C. Dinarello,et al.  Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice , 2013, Gut.

[19]  Sarah L. Westcott,et al.  Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform , 2013, Applied and Environmental Microbiology.

[20]  Rob Knight,et al.  Advancing our understanding of the human microbiome using QIIME. , 2013, Methods in enzymology.

[21]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[22]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[23]  Tarah Lynch,et al.  Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.

[24]  R. Knight,et al.  UniFrac: an effective distance metric for microbial community comparison , 2011, The ISME Journal.

[25]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[26]  E. Dervişoğlu,et al.  Citrobacter freundii peritonitis and tunnel infection in a patient on continuous ambulatory peritoneal dialysis. , 2008, Journal of medical microbiology.

[27]  Byung Tae Kim,et al.  Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[28]  S. Yasuda,et al.  Factors influencing physiological FDG uptake in the intestine. , 1998, The Tokai journal of experimental and clinical medicine.

[29]  S. V. van Deventer.  Tumour necrosis factor and Crohn's disease. , 1997, Gut.

[30]  K. Luh,et al.  Bacteremia due to Citrobacter species: significance of primary intraabdominal infection. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  D. Faith.  Conservation evaluation and phylogenetic diversity , 1992 .

[32]  U. Neisser.  Cognitive Psychology: Classic Edition , 1967 .

[33]  E. C. Pielou.  The measurement of diversity in different types of biological collections , 1966 .